Very poor rhetoric.
i’m far from a downramper. FPH has one of the best track records on the NZX but regardless of that you can’t be myopic enough to deny a ttm P E of 62 for a mature company is not overexuberant nearing ridiculous.
Printable View
Would any of their respiratory products be of any use with coronavirus respiratory problems?
Short answer, yes.
Latest FPH (Friday) and 3rd profit upgrade so far this year linked to better than expected sales of Home Care products, continued strong demand for Hospital Product Group and increasing demand from China linked to COVAD-19 Corona virus.
Just some observations,
As these classified as Essential medical devices, no disruption to supply or distribution channels.
Staff now working long hours trying to keep up with demand.
No devices manufactured in China.
Products sold in over 120 countries worldwide.
Don't want to be accused of up ramping so draw your own conclusions, but since COVAD-19 now spreading rapidly to 20 something countries including the US, Europe & Middle East, think it reasonable to predict there might be some significantly increasing demand.
Is there any thoughts regarding 2020 sales?
If sales are up 25% on forecast to $1.5b then EBIT $475m?,PE down to 40?
Thoughts ?
This baby is going gang buster. It is now the largest company worth in excess of $15B
https://www.nzherald.co.nz/business/...ectid=12313529
New all time high on a red red day. Low was $25 but it finished on its high $26.77 on a last trade of re 250,000 shares.More than defensive atpit:).
will crash soon too
A respiratory pandemic sweeping the world with hospitals & health systems desperately short of respiratory equipment to cope with the numbers, AND an extraordinary company (FPH) selling to over 120 countries, making & continuing to develop the Gold Standard in Respiratory Devices for both hospital & home care (allowing home isolation & saving hospital beds ).
Even once this pandemic passes, heath systems will not ever want to be caught short again.
Connect the dots!
Cant wait to pick this up again at $1.10